Cargando…
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria
The clinical manifestations of cerebral malaria (CM) are well correlated with underlying major pathophysiological events occurring during an acute malaria infection, the most important of which, is the adherence of parasitized erythrocytes to endothelial cells ultimately leading to sequestration and...
Autores principales: | Mimche, Patrice N, Taramelli, Donatella, Vivas, Livia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059458/ https://www.ncbi.nlm.nih.gov/pubmed/21411011 http://dx.doi.org/10.1186/1475-2875-10-S1-S10 |
Ejemplares similares
-
Modulation of cerebral malaria by curcumin as an adjunctive therapy
por: Jain, Kunal, et al.
Publicado: (2013) -
In vitro study of parasite elimination and endothelial protection by curcumin: adjunctive therapy for cerebral malaria
por: Kunwittaya, Sarun, et al.
Publicado: (2014) -
Pentoxifylline as an adjunct therapy in children with cerebral malaria
por: Lell, Bertrand, et al.
Publicado: (2010) -
Adjunctive therapies and immunomodulating agents for severe influenza
por: Hui, David S. C., et al.
Publicado: (2013) -
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
por: Serghides, Lena
Publicado: (2012)